A Prospective Multi-centre Observational Cohort Study Assessing the Effectiveness of Cortiment for the Treatment of Mild-to-moderate Active Ulcerative Colitis in Routine Clinical Practice
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 22 Feb 2018
At a glance
- Drugs Budesonide (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Acronyms CORE Practice
- Sponsors Ferring Pharmaceuticals
- 12 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 09 Nov 2017 Planned End Date changed from 1 Feb 2018 to 1 Sep 2018.
- 09 Nov 2017 Planned primary completion date changed from 1 Feb 2018 to 1 Sep 2018.